Chemotherapy for advanced non-small cell lung cancer

被引：0
作者：
Einhorn, L. [1 ]
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
来源：
LUNG CANCER | 2006年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 15 条
[1]   EVALUATION OF CISPLATIN INTENSITY IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A PHASE-III STUDY OF THE SOUTHWEST-ONCOLOGY-GROUP [J].
GANDARA, DR ;
CROWLEY, J ;
LIVINGSTON, RB ;
PEREZ, EA ;
TAYLOR, CW ;
WEISS, G ;
NEEFE, JR ;
HUTCHINS, LF ;
ROACH, RW ;
GRUNBERG, SM ;
BRAUN, TJ ;
NATALE, RB ;
BALCERZAK, SP .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :873-878
[2]  
GATZEMEIER U, 2004, P AN M AM SOC CLIN, V23, P617
[3]   Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase III trial-INTACT1 [J].
Giaccone, G ;
Herbst, RS ;
Manegold, C ;
Scagliotti, G ;
Rosell, R ;
Miller, V ;
Natale, RB ;
Schiller, JH ;
von Pawel, J ;
Pluzanska, A ;
Gatzemeier, M ;
Grous, J ;
Ochs, JS ;
Averbuch, SD ;
Wolf, MK ;
Rennie, P ;
Fandi, A ;
Johnson, DH .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :777-784
[4]   Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy [J].
Hanna, N ;
Shepherd, FA ;
Fossella, FV ;
Pereira, JR ;
De Marinis, F ;
von Pawel, J ;
Gatzemeier, U ;
Tsao, TCY ;
Pless, M ;
Muller, T ;
Lim, HL ;
Desch, C ;
Szondy, K ;
Gervais, R ;
Shaharyar ;
Manegold, C ;
Paul, S ;
Paoletti, P ;
Einhorn, L ;
Bunn, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) :1589-1597
[5]   Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: A phase III trial - INTACT 2 [J].
Herbst, RS ;
Giaccone, G ;
Schiller, JH ;
Natale, RB ;
Miller, V .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :785-794
[6]   TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer [J].
Herbst, RS ;
Prager, D ;
Hermann, R ;
Fehrenbacher, L ;
Johnson, BE ;
Sandler, A ;
Kris, MG ;
Tran, HT ;
Klein, P ;
Li, X ;
Ramies, D ;
Johnson, DH ;
Miller, VA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5892-5899
[7]   Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer [J].
Hotta, K ;
Matsuo, K ;
Ueoka, H ;
Kiura, K ;
Tabata, M ;
Tanimoto, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3852-3859
[8]   A RANDOMIZED STUDY COMPARING A HIGH AND A STANDARD DOSE OF CISPLATIN IN COMBINATION WITH ETOPOSIDE IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CARCINOMA [J].
KLASTERSKY, J ;
SCULIER, JP ;
RAVEZ, P ;
LIBERT, P ;
MICHEL, J ;
VANDERMOTEN, G ;
ROCMANS, P ;
BONDUELLE, Y ;
MAIRESSE, M ;
MICHIELS, T ;
THIRIAUX, J ;
MOMMEN, P ;
DALESIO, O .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) :1780-1786
[9]  
SANDLER AB, 2005, P AN M AM SOC CLIN, V23, P2
[10]   Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J].
Schiller, JH ;
Harrington, D ;
Belani, CP ;
Langer, C ;
Sandler, A ;
Krook, J ;
Zhu, JM ;
Johnson, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02) :92-98
12